Singapore markets closed

Gamida Cell Ltd. (GMDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.3700-0.1900 (-7.42%)
At close: 04:00PM EST
2.4400 +0.07 (+2.95%)
Pre-market: 04:22AM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.5600
Bid0.0000 x 2200
Ask0.0000 x 2200
Day's range2.3555 - 2.6400
52-week range2.3555 - 15.0000
Avg. volume372,755
Market cap140.538M
Beta (5Y monthly)1.84
PE ratio (TTM)N/A
EPS (TTM)-1.5960
Earnings date01 Mar 2022 - 11 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.29
  • Business Wire

    Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences

    BOSTON, November 16, 2021--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that company management will present its corporate highlights at the following upcoming virtual investor conferences:

  • Motley Fool

    Gamida Cell Ltd. (GMDA) Q3 2021 Earnings Call Transcript

    Please be advised that this call is being recorded at Gamida Cell's request. Now, I would like to introduce your host for today's conference, Mr. Josh Hamermesh, chief business officer. Welcome to today's call, during which we will provide an update on the company and review our financial results for the third quarter of 2021.

  • Business Wire

    Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update

    BOSTON, November 15, 2021--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today provided a business update and reported financial results for the quarter ended September 30, 2021. Net loss for the third quarter of 2021 was $19.6 million, compared to a net loss of $14.8 million for the same period in 2020. As of September 30, 2021, Gamida Cell had total cash and cash equivalents of $120.8 million.